[go: up one dir, main page]

HK1068790A - Salts formed of an at1-receptor antagonist and a cardiovascular agent - Google Patents

Salts formed of an at1-receptor antagonist and a cardiovascular agent Download PDF

Info

Publication number
HK1068790A
HK1068790A HK05101209.0A HK05101209A HK1068790A HK 1068790 A HK1068790 A HK 1068790A HK 05101209 A HK05101209 A HK 05101209A HK 1068790 A HK1068790 A HK 1068790A
Authority
HK
Hong Kong
Prior art keywords
receptor antagonist
salts formed
cardiovascular agent
cardiovascular
agent
Prior art date
Application number
HK05101209.0A
Other languages
Chinese (zh)
Inventor
Peter Bühlmayer
Randy Lee Webb
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of HK1068790A publication Critical patent/HK1068790A/en

Links

HK05101209.0A 2001-10-18 2002-10-17 Salts formed of an at1-receptor antagonist and a cardiovascular agent HK1068790A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60/330,337 2001-10-18

Publications (1)

Publication Number Publication Date
HK1068790A true HK1068790A (en) 2005-05-06

Family

ID=

Similar Documents

Publication Publication Date Title
AU2002214626A1 (en) Quaternary amines and related inhibitors of factor xa
AU2002231570A1 (en) Pharmaceutical compositions containing a cox-ii inhibitor and a muscle relaxant
AU2001262089A1 (en) Alpha4beta1 and alpha4beta7 integrin inhibitors
AU1420402A (en) Salts of a isothiazole-4-carboxamide and their use as anti-hyperproliferation agents
AU2002249885A1 (en) Delta agonist analgesics
TW529766U (en) Package of tails and a base of a laser
AU2002337749A1 (en) Pioglitazone hydrochloride
AU2002363087A1 (en) Salts formed of an at1-receptor antagonist and a cardiovascular agent
AU2001287698A1 (en) Combination comprising an at1-receptor antagonist and an insulin secretion enhancer or an insulin sensitiser
IL151589A0 (en) New combination of a betablocker and a cholestrol-lowering agent
AU2002310692A1 (en) Benchmark testing of a computer component
HK1068790A (en) Salts formed of an at1-receptor antagonist and a cardiovascular agent
EP1429747A4 (en) Core formulation comprising pioglitazone hydrochloride and a biguanide
EP1407771A4 (en) Sophoridine and use thereof as an analgesic
AU2001283340A1 (en) Factor viia inhibitors
IL147185A0 (en) A method for the detection of compounds comprising methylenedioxyphenyl and a testing kit for the same
PL374085A1 (en) Method and kit for detecting alkaline sphingomyelinase
AU2002343921A1 (en) Dihydroorotate dehydrogenase inhibitor
AU2002238356A1 (en) New use of phencynonate hydrochloride
AU2002237189A1 (en) New use of phencynonate hydrochloride
GB0030802D0 (en) Packaging regimen of pseudoephedrine hydrochloride and fexofenadine hydrochloride
AU2002316962A1 (en) Combination comprising a p-gp inhibitor and an anti-epileptic drug
AU2003284832A1 (en) Combi-plaster and a nose-bridge plaster forming part thereof
AU2002305836A1 (en) Combination of a ptpase inhibitor and a thiazolidinedione agent
TJ334B (en) A method and device for realization of game chancein bermudas triangle